| Primary |
| Asthma |
64.3% |
| Chronic Obstructive Pulmonary Disease |
15.0% |
| Product Used For Unknown Indication |
3.1% |
| Emphysema |
2.9% |
| Dyspnoea |
2.3% |
| Bronchitis |
1.9% |
| Hypersensitivity |
1.8% |
| Cough |
1.7% |
| Lung Disorder |
1.1% |
| Wheezing |
1.0% |
| Hypertension |
0.8% |
| Respiratory Therapy |
0.7% |
| Pulmonary Fibrosis |
0.6% |
| Bronchitis Chronic |
0.5% |
| Diabetes Mellitus |
0.5% |
| Respiratory Disorder |
0.5% |
| Asthma Prophylaxis |
0.4% |
| Convulsion |
0.4% |
| Pain |
0.4% |
| Pneumonia |
0.4% |
|
| Product Quality Issue |
38.3% |
| Underdose |
7.0% |
| Drug Ineffective |
5.2% |
| No Adverse Event |
4.2% |
| Dysphonia |
4.0% |
| Dyspnoea |
4.0% |
| Muscle Spasms |
3.4% |
| Off Label Use |
3.4% |
| Wheezing |
3.4% |
| Wrong Technique In Drug Usage Process |
3.4% |
| Tremor |
3.1% |
| Candida Infection |
2.7% |
| Headache |
2.7% |
| Asthma |
2.2% |
| Chest Pain |
2.2% |
| Palpitations |
2.2% |
| Product Taste Abnormal |
2.2% |
| Tachycardia |
2.2% |
| Swollen Tongue |
2.1% |
| Rash |
1.9% |
|
| Secondary |
| Asthma |
39.5% |
| Chronic Obstructive Pulmonary Disease |
20.1% |
| Emphysema |
5.4% |
| Product Used For Unknown Indication |
5.4% |
| Cough |
4.1% |
| Hypersensitivity |
4.1% |
| Hypertension |
3.1% |
| Bronchitis Chronic |
2.7% |
| Bronchitis |
2.4% |
| Cardiac Disorder |
2.0% |
| Dyspnoea |
2.0% |
| Lung Disorder |
2.0% |
| Wheezing |
1.4% |
| Arthritis |
1.0% |
| Muscle Twitching |
1.0% |
| Pulmonary Fibrosis |
1.0% |
| Bacterial Infection |
0.7% |
| Blood Cholesterol Increased |
0.7% |
| Depression |
0.7% |
| Diabetes Mellitus |
0.7% |
|
| Product Quality Issue |
30.7% |
| Dysphonia |
8.8% |
| Wheezing |
7.0% |
| Swollen Tongue |
5.3% |
| Drug Ineffective |
4.4% |
| Product Container Issue |
4.4% |
| Weight Increased |
4.4% |
| Tremor |
3.5% |
| Underdose |
3.5% |
| Urticaria |
3.5% |
| Dyspnoea |
2.6% |
| Fatigue |
2.6% |
| Hypersensitivity |
2.6% |
| Pneumonia |
2.6% |
| Speech Disorder |
2.6% |
| Therapeutic Response Decreased |
2.6% |
| Vocal Cord Inflammation |
2.6% |
| Wrong Technique In Drug Usage Process |
2.6% |
| Drug Hypersensitivity |
1.8% |
| Foetal Exposure During Pregnancy |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
35.5% |
| Asthma |
15.9% |
| Chronic Obstructive Pulmonary Disease |
13.0% |
| Hypertension |
4.8% |
| Depression |
3.3% |
| Hypersensitivity |
3.1% |
| Pain |
2.8% |
| Crohn's Disease |
2.6% |
| Anxiety |
2.4% |
| Gastrooesophageal Reflux Disease |
2.4% |
| Dyspnoea |
1.9% |
| Rheumatoid Arthritis |
1.8% |
| Blood Cholesterol Increased |
1.7% |
| Diabetes Mellitus |
1.7% |
| Migraine |
1.4% |
| Insomnia |
1.3% |
| Rhinitis Allergic |
1.3% |
| Vitamin Supplementation |
1.2% |
| Hypothyroidism |
1.1% |
| Sleep Disorder |
1.1% |
|
| Product Quality Issue |
11.2% |
| Wheezing |
7.7% |
| Pneumonia |
7.0% |
| Dyspnoea |
6.3% |
| Incorrect Route Of Drug Administration |
6.3% |
| Vomiting |
5.6% |
| Pyrexia |
4.9% |
| Sinusitis |
4.9% |
| Weight Increased |
4.9% |
| Chronic Obstructive Pulmonary Disease |
4.2% |
| Drug Ineffective |
4.2% |
| Off Label Use |
4.2% |
| Tremor |
4.2% |
| Vision Blurred |
4.2% |
| Injection Site Pain |
3.5% |
| Malaise |
3.5% |
| Pain |
3.5% |
| Upper Respiratory Tract Infection |
3.5% |
| Urticaria |
3.5% |
| Asthma |
2.8% |
|
